Aligos Therapeutics, Inc.

ALGSNASDAQ Global Select·USD·Closed

ALGSNASDAQ·USD·Closed

$5.11

−4.31%

$5.11

−$0.23 (4.31%)

52W Range

1thpctl

Volume

0.11×avg

Mkt Cap

31.62MUSD

P/E

-0.6TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

1thpctl

Volume

0.11×avg

Market Cap

31.62MUSD

P/E Ratio

-0.6TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-44.6% / yr

Operating margin-2033.4%

ROIC-212.9%

Financially safe

Stretched

Debt / equity0.14×

Interest coverage0.0×

Current ratio2.56×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required